🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Stage II Cutaneous Melanoma

A Study of IBI363 in Subjects With Advanced Melanoma NCT06081920Phase 212 sites📍 Beijing📍 Beijing📍 Fuzhou Innovent Biologics (Suzhou) Co. Ltd. · Tests: IBI363 A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients NCT01638676Phase 1, Phase 21 site📍 Louisville University of Louisville · Tests: Vemurafenib, Metformin COmparison of the Use of a PERforator Flap Versus Total Skin GRAft in the Management of Loss of Substance After Resection of Cutaneous Melanoma - Pilot Study NCT07354152n/a1 site📍 Nantes Nantes University Hospital Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma NCT05830058Phase 22 sites📍 Duarte📍 Irvine City of Hope Medical Center · Tests: Biospecimen Collection, Computed Tomography, Positron Emission Tomography, Questionnaire Administration, Stereotactic B… A Study of TRK-950 in Patients With Advanced Solid Tumors NCT05423262Phase 1, Phase 210 sites📍 Nagoya📍 Fukuoka📍 Sapporo Toray Industries, Inc · Tests: TRK-950, TRK-950, TRK-950, Nivolumab, TRK-950 Neoadjuvant Pembrolizumab in Patients With Stage IIb/c Melanoma NCT07349303Phase 21 site📍 Gothenburg Vastra Gotaland Region · Tests: Pembrolizumab, Placebo Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma NCT07136181Phase 1, Phase 23 sites📍 Scottsdale📍 Denver📍 Nashville Novelwise Pharmaceutical Corporation · Tests: NBM-BMX Capsule are proprietary products developed by Novelwise Pharmaceutical Corporation (Novelwise) for treatment of… Anti PD-1 Plus Postbiotic Versus Anti PD-1 Alone in Locally Advanced or Metastatic, Treatment naïve, Cutaneous Melanoma Study NCT07050940NA5 sites📍 Bari📍 Torino📍 Bari Azienda Ospedaliera di Perugia · Tests: Postbiotic, AntiPD1 Evaluation of a Personalised Survivorship Care Plan App for Patients With Melanoma NCT06643286NA4 sites📍 Dordrecht📍 Rotterdam📍 Rotterdam Erasmus Medical Center · Tests: Digizorg Melanoma app Intradermal Ipilimumab and Nivolumab in High Risk Stage II Melanoma NCT06240143Phase 1, Phase 26 sites📍 Amsterdam📍 Amsterdam📍 Groningen The Netherlands Cancer Institute · Tests: Ipilimumab, Nivolumab, Nivolumab Perioperative Toripalimab and Endostatin for Stage II Melanoma: A Phase II Trial NCT06965231Phase 24 sites📍 Shanghai📍 Shanghai📍 Shanghai Fudan University · Tests: Toripalimab combined with Endostar A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information NCT07621614Phase 213 sites📍 Oakland📍 Wilmington📍 Jacksonville Children's Oncology Group · Tests: Biospecimen Collection, Chest Radiography, Computed Tomography, Fludeoxyglucose F-18, Magnetic Resonance Imaging An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors NCT07371663Phase 1, Phase 23 sites📍 Beijing📍 Zhengzhou📍 Hangzhou Beijing Tide Pharmaceutical Co., Ltd · Tests: TCC1727 tablet 90mg, TCC1727 tablet 120mg, TCC1727 tablet 160mg, benmelstobart Injection Modified Vaccine for High Risk or Low Residual Melanoma Patients NCT01898039Phase 1, Phase 21 site📍 Jerusalem Hadassah Medical Organization · Tests: A2/4-1BBL melanoma vaccine, DNP sensititzation, Cyclophosphamide Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors NCT05280314Phase 215 sites📍 New Haven📍 Boston📍 Richmond IO Biotech · Tests: IO102-IO103, Pembrolizumab KEYTRUDA® Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers NCT05296564Phase 1, Phase 21 site📍 Jerusalem Hadassah Medical Organization · Tests: CYCLOPHOSPHAMIDE and FLUDARABIN, Cyclophosphamide, HBI 0201-ESO TCRT, Aldesleukin Neoadjuvant Tebentafusp for Uveal Melanoma NCT06414590Phase 22 sites📍 Philadelphia📍 Philadelphia Thomas Jefferson University · Tests: Tebentafusp-Tebn RAPA-201 Therapy of Solid Tumors NCT05144698Phase 1, Phase 21 site📍 Hackensack Rapa Therapeutics LLC · Tests: RAPA-201 Rapamycin Resistant T Cells, Chemotherapy Prior to RAPA-201 Therapy, Pembrolizumab (PD-1 Blocking Antibody) A Randomized Controlled Phase II Trial With Intradermal IMO-2125 in Pathological Tumor Stage (p) T3-4 cN0M0 Melanoma NCT04126876Phase 21 site📍 Amsterdam A.J.M. van den Eertwegh · Tests: Tilsotolimod, Saline (0.9% sodium chloride) Follow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable Primary NCT02828202n/a27 sites📍 Amiens📍 Annecy📍 Besançon Assistance Publique - Hôpitaux de Paris · Tests: Biological, Tissular, Quality of life Investigating the Combination of Bexmarilimab and Nivolumab in Solid Tumours, Melanoma and NSCLC NCT07718243Phase 1, Phase 22 sites📍 Manchester📍 Sutton Institute of Cancer Research, United Kingdom · Tests: Bexmarilimab 1mg/kg and nivolumab 1mg/kg, Bexmarilimab 3mg/kg and nivolumab 1mg/kg, Recommended Phase II Dose Phase II Study of Nivolumab in Combination With Relatlimab in Patients With Active Melanoma Brain Metastases NCT05704647Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: BMS-986213 (Relatlimab-Nivolumab FDC), Nivolumab, Relatlimab Neoadjuvant SHR-1210 Plus Apatinib for Resectable Stage III-IV Acral Melanoma NCT04331093Phase 21 site📍 Changchun Di Wu · Tests: SHR-1210+Apatinib Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma NCT04697576Phase 11 site📍 Columbus Carlo Contreras · Tests: Ipilimumab, Nivolumab, Pembrolizumab, Quadrivalent Inactivated Influenza Vaccine, Resection A Study to Evaluate the Efficacy and Safety of IBI363 Monotherapy Compared to Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal or Acral Melanoma Who Had Not Previously Received Systemic Therapy NCT06797297Phase 231 sites📍 Hefei📍 Beijing📍 Beijing Innovent Biologics (Suzhou) Co. Ltd. · Tests: IBI363, Pembrolizumab Cryoablation Combined With Hepatic Arterial Infusion of Iparomlimab and Tuvonralimab (QL1706), Intravenous Dacarbazine, and Oral Lenvatinib in Patients With Liver Metastases From Malignant Melanoma: a Single-arm, Phase II, Prospective Trial NCT07847359Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Cryoablation, Iparomlimab and Tuvonralimab, Dacarbazine, Lenvatinib Cryoablation+Ipilimumab+Nivolumab in Melanoma NCT05779423Phase 21 site📍 Boston Massachusetts General Hospital · Tests: Ipilimumab, Nivolumab, Cryoablation OH2 Injection in Combination With HX008 for Melanoma. NCT04616443Phase 1, Phase 21 site📍 Beijing Binhui Biopharmaceutical Co., Ltd. · Tests: OH2 injection, HX008 injection Social Prescriptions and Micro-Learning to Improve Care for Cancer Patients and Their Support Persons NCT07788729NA8 sites📍 Augsburg📍 Erlangen📍 Regensburg University of Regensburg · Tests: PRISMA-interventions Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer NCT03819296Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Best Practice, Biospecimen Collection, Endoscopic Procedure, Fecal Microbiota Transplantation, Infliximab
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy